The Role of Surgery in the Management of Prolactinomas.
Hyperprolactinemia
Pituitary
Prolactinoma
Surgery
Transsphenoidal
Journal
Neurosurgery clinics of North America
ISSN: 1558-1349
Titre abrégé: Neurosurg Clin N Am
Pays: United States
ID NLM: 9008004
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
entrez:
1
9
2019
pubmed:
1
9
2019
medline:
23
2
2020
Statut:
ppublish
Résumé
Prolactinomas are the most common functional pituitary adenoma. Many prolactinomas can be treated with medication, but all patients should be evaluated at a neuroendocrine center including experienced neurosurgeons trained in transsphenoidal surgery. Surgery for prolactinomas is feasible and can be performed with low morbidity. Patients never previously treated with dopamine agonists should be considered for surgery if they have neurologic deficits, pituitary apoplexy, an uncertain diagnosis, or a significantly cystic prolactinoma. Patients previously treated with dopamine agonists should be considered for surgery in cases of intolerance or resistance. Recurrent and aggressive prolactinomas often require multimodal therapy.
Identifiants
pubmed: 31471058
pii: S1042-3680(19)30046-4
doi: 10.1016/j.nec.2019.05.010
pii:
doi:
Substances chimiques
Dopamine Agonists
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
509-514Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.